Home Intralink Spine

Intralink Spine

    Intralink-Spine, Inc. Announces ISO-13485 Certification

    The certification process included an on-site audit of ILS’s newly constructed GMP manufacturing facility in Lexington, KY.

    Intralink-Spine Expands Clinical Studies in Australia

    The company reports the Réjuve treatment has the potential to fill the gap between non-operative treatments and surgery.

    Intralink-Spine, Inc. Announces Initiation of Clinical Trials in Australia for their Patented Device Réjuve™

    3/5/19: According to Hawkins, “We believe the Réjuve medical device, which structurally reinforces the native intervertebral disc itself, is going to be a better treatment option for many patients with low back pain.

    Intralink-Spine Expands Clinical Studies To Multiple Sites and Locations

    3/27/18: Company has restructured for growth and to better position themselves for a successful CE submission.

    New Data for Intralink-Spine’s Réjuve Treatment for Low Back Pain

    “We’ve demonstrated the safety of this device, and it has performed as expected. The dramatic pain reduction in these patients correlated with some objective...